Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
1(8%)
Results Posted
44%(4 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_3
2
15%
Ph phase_4
7
54%
Ph not_applicable
4
31%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution13 total trials
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(9)
Terminated(2)
Other(1)

Detailed Status

Completed9
Terminated2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (15.4%)
Phase 47 (53.8%)
N/A4 (30.8%)

Trials by Status

completed969%
unknown18%
terminated215%
active_not_recruiting18%

Recent Activity

1 active trials
Showing 5 of 13
active_not_recruitingnot_applicable

Insulin Detemir in Obesity Management

NCT01239550
completedphase_4

Detemir Energy Expenditure Study

NCT00788840
completednot_applicable

Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

NCT01186003
completedphase_4

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

NCT01966978
completednot_applicable

Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes

NCT00522210
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT01239550Not Applicable

Insulin Detemir in Obesity Management

Active Not Recruiting
NCT00788840Phase 4

Detemir Energy Expenditure Study

Completed
NCT01186003Not Applicable

Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

Completed
NCT01966978Phase 4

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

Completed
NCT00522210Not Applicable

Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes

Completed
NCT01461616Phase 3

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis

Completed
NCT00717288Phase 4

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

Completed
NCT01271517Phase 4

Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis

Unknown
NCT00457093Not Applicable

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

Completed
NCT00699686Phase 4

Endothelial Effects of Basal Insulin: Detemir Versus Glargine

Completed
NCT00494013Phase 3

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Completed
NCT00490893Phase 4

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

Terminated
NCT00135070Phase 4

Hospital In-Patient Insulin Study

Terminated

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13